SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-21-000040
Filing Date
2021-03-18
Accepted
2021-03-18 16:32:26
Documents
4
Effectiveness Date
2021-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_2021planincrease.htm S-8 84464
2 EX-5.1 alpn-ex51_20210318.htm EX-5.1 7297
3 EX-23.1 alpn-ex231_20210318.htm EX-23.1 2604
4 alpnex5120200330image1a011a.gif GRAPHIC 3199
  Complete submission text file 0001626199-21-000040.txt   100123
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254446 | Film No.: 21754771
SIC: 2834 Pharmaceutical Preparations